[{"NetIncomeLoss_3_Q3_USD":59400000.0,"OperatingLeaseLiability_0_Q3_USD":92700000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_3_Q3_USD":29700000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":4800000.0,"InterestPaidNet_3_Q3_USD":5800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":3200000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":3200000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":151800000.0,"Depreciation_3_Q3_USD":6400000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":170500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":11200000.0,"AssetsCurrent_0_Q3_USD":1156900000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":399200000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":1800000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":326800000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":7200000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":2700000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":21600000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2500000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":425000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":10900000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":1800000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-1400000.0,"IncomeTaxesPaidNet_3_Q3_USD":400000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":557400000.0,"CommonStockSharesIssued_0_Q3_shares":93400000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":1000000.0,"Assets_0_Q3_USD":1502600000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":112500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1400000.0,"Investments_0_Q3_USD":1173000000.0,"Liabilities_0_Q3_USD":698300000.0,"EarningsPerShareBasic_1_Q3_USD":-0.62,"EarningsPerShareBasic_3_Q3_USD":0.64,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":-12200000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":-7000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":98000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":93300000.0,"AccountsReceivableNetCurrent_0_Q3_USD":156900000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":5600000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":500000.0,"CommonStockValue_0_Q3_USD":100000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":181400000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_security":14.0,"DebtInstrumentUnamortizedDiscountPremiumNet_0_Q3_USD":86600000.0,"DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":28100000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":208300000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":69100000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":21600000.0,"CostsAndExpenses_3_Q3_USD":706800000.0,"CostsAndExpenses_1_Q3_USD":302800000.0,"ConvertibleDebtCurrent_0_Q3_USD":425000000.0,"OtherAssetsCurrent_0_Q3_USD":34700000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3400000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":61200000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-59000000.0,"OtherAssetsNoncurrent_0_Q3_USD":3400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":425300000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":83000000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1874300000.0,"ShareBasedCompensation_3_Q3_USD":79000000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":126100000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":71000000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":21600000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1000000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":1700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":65000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-57100000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":79000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":26700000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":139600000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":14800000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_3_Q3_USD":164500000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q3_USD":118500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":93000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":93300000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":10600000.0,"PaymentsToAcquireRestrictedInvestments_3_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":611000000.0,"NonoperatingIncomeExpense_1_Q3_USD":-12800000.0,"InterestExpense_3_Q3_USD":25000000.0,"InterestExpense_1_Q3_USD":8500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":428500000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.058,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":5600000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":2900000.0,"OperatingLeasePayments_3_Q3_USD":6400000.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q3_USD":180300000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1100000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":43000000.0,"NetIncomeLoss_1_Q3_USD":-57600000.0,"NonoperatingIncomeExpense_3_Q3_USD":-26200000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.62,"EarningsPerShareDiluted_3_Q3_USD":0.61,"CommonStockSharesOutstanding_0_Q3_shares":93400000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"InterestReceivableCurrent_0_Q3_USD":3500000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":33400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":11600000.0,"DebtInstrumentFaceAmount_0_Q3_USD":517500000.0,"DeferredFinanceCostsNet_0_Q3_USD":5900000.0,"CommonStockSharesAuthorized_0_Q3_shares":220000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":798000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":258500000.0,"OperatingIncomeLoss_3_Q3_USD":91200000.0,"OperatingIncomeLoss_1_Q3_USD":-44300000.0,"EquitySecuritiesFvNiRestricted_0_Q3_USD":43700000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q3_USD":517300000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":519400000.0,"InventoryNet_0_Q3_USD":20600000.0,"PreferredStockValue_0_Q3_USD":0.0,"OperatingLeaseCost_3_Q3_USD":7400000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1502600000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":15200000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":9700000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":4300000.0,"OtherLiabilitiesCurrent_0_Q3_USD":15500000.0,"StockholdersEquity_0_Q3_USD":804300000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6400000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":428500000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1073300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":313000000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":30300000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2100000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]